+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Microbiome Diagnostics Market by Product Type (Instruments, Reagents & Kits), Application (Gastrointestinal Disorders, Infectious Diseases, Metabolic Disorders), End-user - Forecast 2024-2030- Product Image
Global Microbiome Diagnostics Market by Product Type (Instruments, Reagents & Kits), Application (Gastrointestinal Disorders, Infectious Diseases, Metabolic Disorders), End-user - Forecast 2024-2030- Product Image
Sale

Global Microbiome Diagnostics Market by Product Type (Instruments, Reagents & Kits), Application (Gastrointestinal Disorders, Infectious Diseases, Metabolic Disorders), End-user - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968243
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Microbiome Diagnostics Market size was estimated at USD 799.36 million in 2023, USD 960.27 million in 2024, and is expected to grow at a CAGR of 20.72% to reachUSD 2.98 billion by 2030.

These diagnostic methods leverage high-throughput sequencing technologies and bioinformatics tools to identify, categorize, and understand the diverse array of microorganisms, including bacteria, viruses, fungi, and other microbes, that coexist in particular habitats, notably the gut, skin, and oral cavities among others. This field aims to shed light on the complex interactions between these microorganisms and their host, contributing significantly to the understanding of health and disease states, thereby offering potential pathways for novel therapeutic and diagnostic developments. Microbiome diagnostics has a crucial role in personalized medicine, enabling the creation of more precise, individualized approaches to treatment and prevention strategies based on the unique microbiome compositions of individuals. The rising prevalence of chronic diseases and the critical role of the microbiome in diagnosing these conditions has driven the adoption of microbiome diagnostics methods globally. Additionally, government initiatives and support have substantially boosted research in this domain, further propelling the microbiome diagnostics market forward. Despite the promising growth, the microbiome diagnostics market faces challenges owing to the lack of reimbursement policies, which can hinder patient access to these innovative tests. However, the surge in investment for microbiome-based research is catalyzing the development of innovative diagnostics tools, creating a future growth landscape for the market.

Regional Insights

The microbiome diagnostics market in the Americas is experiencing significant growth, primarily driven by increased research and development activities in the United States and Canada. The region's strong healthcare infrastructure, coupled with a high prevalence of gastrointestinal diseases and growing awareness about the importance of microbiome balance, are key factors driving the adoption of microbiome diagnostics in the region. In the EMEA region, Europe stands out as a major contributor to the microbiome diagnostics market, supported by numerous government and private research initiatives aimed at understanding the human microbiome's role in health and disease. The Middle East and Africa are showing promising growth, with an increasing number of studies focusing on the microbiome's link to prevalent diseases in these areas. Asia-Pacific is witnessing the fastest growth in the microbiome diagnostics market, owing to rapidly improving healthcare infrastructures and increasing investments in microbiome research in China, Japan, and South Korea. Moreover, a large patient pool and growing awareness about microbiome testing drive the need for microbiome diagnostics in the region.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Microbiome Diagnostics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising prevalence of chronic diseases and significance of microbiome-based diagnostics
  • Government initiatives and support for microbiome research

Market Restraints

  • Lack of reimbursement policies for microbiome-based diagnostics

Market Opportunities

  • Increasing investment in microbiome-based research
  • Growing potential of microbiome diagnostics in developing personalized treatments

Market Challenges

  • Lack of standardized protocols and available therapeutics targeting the microbiome

Market Segmentation Analysis

  • Product Type: Need for accurate and efficient instruments capable of handling complex analyses
  • End-user: Growing adoption of microbiome diagnostics in pharmaceutical and biotechnology companies to develop personalized therapies

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Microbiome Diagnostics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Microbiome Diagnostics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Launch of “Targeted Microbiome Profiling”, a pathway-based microbiome profiling service for health and disease

TenWise BV and Predica Diagnostics BV, supported financially by the Dutch RVO (MIT-R&D-samenwerkingsproject), have unveiled the Targeted Microbiome Profiling (TMP) service. This cutting-edge service employs Predica's groundbreaking ciRNAseq technology along with TenWise's prowess in literature mining, artificial intelligence, and algorithm development, providing a comprehensive analysis of microbiome communities. TMP accelerates the microbiome profiling process and deciphers the biological pathways influencing microbiome functionality by analyzing extracted RNA from various microbiome niches.

Evvy, Precision Women’s Health Startup focused on the Vaginal Microbiome, Announces USD 14 million Series A

Evvy announced a successful Series A financing round, securing USD 14 million. The venture was led by Left Lane Capital, along with significant contributions from General Catalyst, Labcorp Venture Fund, and several other distinguished investors. Evvy has been at the forefront of women’s healthcare by pioneering a groundbreaking approach to understanding female biomarkers, with a primary focus on the vaginal microbiome.

Xume partners with Microbiome.in and TruDiagno to help people make gut microbiome-informed choices

Xume has strategically partnered with Microbiome.in (Microbiome Research Pvt Ltd) and TruDiagno. This collaboration marks a significant milestone, melding Xume's pioneering AI technology with Microbiome. in's groundbreaking gut microbiome research and TruDiagno's advanced molecular diagnostics expertise. Together, they are setting a new standard in preventive healthcare by offering bespoke diagnostic insights, enabling individuals to make informed lifestyle and dietary choices without compromise.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Microbiome Diagnostics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Microbiome Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 4D Pharma PLC, AOBiome Therapeutics, Atlas Biomed, BioGaia, BIOHM Health, Bione Ventures Private Limited, DayTwo, DNA Genotek Inc. by OraSure Technologies Inc., Du Pont De Nemours and Co., Enterome, Evvy, Ferring Pharmaceuticals, Finch Therapeutics Group, Flightpath Biosciences, Inc., Genetic Analysis AS, Gnubiotics Sciences, International Flavors & Fragrances Inc, Luxia Scientific, MEtabiomics, Microba Life Sciences, OptiBiotix Health PLC, Osel Inc., Quantbiome, Inc., Rebiotix, Second Genome, Inc., Seed Health, Seres Therapeutics, Sun Genomics, Symbiotix Biotherapies,, Synlogic, Inc., Synthetic Biologics, Vedanta Biosciences, Inc., Viome Life Sciences, Inc., ViThera, ViThera Pharmaceuticals, Inc., Yakult Honsha Co., and YSOPIA Bioscience.

Market Segmentation & Coverage

This research report categorizes the Microbiome Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type

  • Instruments
  • Reagents & Kits

Application

  • Gastrointestinal Disorders
  • Infectious Diseases
  • Metabolic Disorders

End-user

  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic diseases and significance of microbiome-based diagnostics
5.1.1.2. Government initiatives and support for microbiome research
5.1.2. Restraints
5.1.2.1. Lack of reimbursement policies for microbiome-based diagnostics
5.1.3. Opportunities
5.1.3.1. Increasing investment in microbiome-based research
5.1.3.2. Growing potential of microbiome diagnostics in developing personalized treatments
5.1.4. Challenges
5.1.4.1. Lack of standardized protocols and available therapeutics targeting the microbiome
5.2. Market Segmentation Analysis
5.2.1. Product Type: Need for accurate and efficient instruments capable of handling complex analyses
5.2.2. End-user: Growing adoption of microbiome diagnostics in pharmaceutical and biotechnology companies to develop personalized therapies
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Microbiome Diagnostics Market, by Product Type
6.1. Introduction
6.2. Instruments
6.3. Reagents & Kits
7. Microbiome Diagnostics Market, by Application
7.1. Introduction
7.2. Gastrointestinal Disorders
7.3. Infectious Diseases
7.4. Metabolic Disorders
8. Microbiome Diagnostics Market, by End-user
8.1. Introduction
8.2. Pharmaceutical & Biotechnology Companies
8.3. Research & Academic Institutes
9. Americas Microbiome Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Microbiome Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Microbiome Diagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Launch of “Targeted Microbiome Profiling”, a pathway-based microbiome profiling service for health and disease
12.3.2. Evvy, Precision Women’s Health Startup focused on the Vaginal Microbiome, Announces USD 14 million Series A
12.3.3. Xume partners with Microbiome.in and TruDiagno to help people make gut microbiome-informed choices
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. MICROBIOME DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. MICROBIOME DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MICROBIOME DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. MICROBIOME DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. MICROBIOME DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. MICROBIOME DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 28. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 35. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 36. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 41. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 42. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 47. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 48. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 49. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. CANADA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 54. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 55. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 58. MEXICO MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 59. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 60. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 68. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 75. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 76. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 81. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 82. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 83. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 88. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 89. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. INDIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 94. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 99. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 100. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 101. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 104. JAPAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 105. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 106. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 111. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 112. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 117. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 118. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 124. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 129. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 130. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 135. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 136. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 137. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. THAILAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 142. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 155. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 156. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 157. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. DENMARK MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 162. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 163. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. EGYPT MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 168. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 169. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. FINLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 174. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 175. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 178. FRANCE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 179. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 180. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 181. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 184. GERMANY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 185. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 186. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 192. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 193. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 196. ITALY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 197. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 198. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 204. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 209. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 210. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 211. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 214. NORWAY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 215. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 216. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 217. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. POLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 222. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 223. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. QATAR MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 228. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 234. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 240. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 245. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 246. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 247. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. SPAIN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 252. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 258. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 263. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 264. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 265. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. TURKEY MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 276. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM MICROBIOME DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 281. MICROBIOME DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 282. MICROBIOME DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • 4D Pharma PLC
  • AOBiome Therapeutics
  • Atlas Biomed
  • BioGaia
  • BIOHM Health
  • Bione Ventures Private Limited
  • DayTwo
  • DNA Genotek Inc. by OraSure Technologies Inc.
  • Du Pont De Nemours and Co.
  • Enterome
  • Evvy
  • Ferring Pharmaceuticals
  • Finch Therapeutics Group
  • Flightpath Biosciences, Inc.
  • Genetic Analysis AS
  • Gnubiotics Sciences
  • International Flavors & Fragrances Inc
  • Luxia Scientific
  • MEtabiomics
  • Microba Life Sciences
  • OptiBiotix Health PLC
  • Osel Inc.
  • Quantbiome, Inc.
  • Rebiotix
  • Second Genome, Inc.
  • Seed Health
  • Seres Therapeutics
  • Sun Genomics
  • Symbiotix Biotherapies,
  • Synlogic, Inc.
  • Synthetic Biologics
  • Vedanta Biosciences, Inc.
  • Viome Life Sciences, Inc.
  • ViThera
  • ViThera Pharmaceuticals, Inc.
  • Yakult Honsha Co.
  • YSOPIA Bioscience

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 960.27 Million
Forecasted Market Value ( USD ) by 2030 $ 2987.87 Million
Compound Annual Growth Rate20.7%
Regions CoveredGlobal
No. of Companies Mentioned37

Related Topics

Related Reports

Global Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Forecast 2024-2030 - Product Image

Global Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Global Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Forecast to 2028 - Product Image

Global Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Forecast to 2028

  • Report
  • 179 Pages
  • Global
From
Global Cancer Microbiome Sequencing Market by Product (Kits & Assays, Service, Software), Technology (Next-Generation Sequencing, Polymerase Chain Reaction), Application, End User - Forecast 2024-2030 - Product Image

Global Cancer Microbiome Sequencing Market by Product (Kits & Assays, Service, Software), Technology (Next-Generation Sequencing, Polymerase Chain Reaction), Application, End User - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030] - Product Image

Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030]

  • Report
  • 209 Pages
  • Global
From
Global Cancer Microbiome Market Report and Forecast 2024-2032 - Product Image

Global Cancer Microbiome Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From

About the Microbiome Diagnostics Market

Within the field of biotechnology, the microbiome diagnostics market encompasses a range of technologies and products aimed at analyzing and understanding the complex communities of microorganisms, particularly bacteria and fungi, that inhabit various environments, including the human body. These diagnostics are crucial for advancing the comprehension of the human microbiome and its impact on health and disease. This market leverages advancements in genomics, proteomics, and bioinformatics to identify microbial compositions in different biological samples. The applications of microbiome diagnostics are broad, ranging from identifying dysbiosis associated with disease states to predicting the response to therapeutics and personalizing treatment plans. Microbiome diagnostics play a pivotal role in preventive medicine, nutrition, and the development of targeted therapies by providing insights into the correlation between microbial flora and patient outcomes. The approach has been especially fruitful in the areas of gastrointestinal and metabolic diseases, where the gut microbiome is known to have a major influence. Additionally, the research in this field is rapidly expanding, with discoveries regularly enhancing the potential of microbiome-based diagnostics and therapeutics. Several companies have established themselves in the microbiome diagnostics market, contributing to its growth and innovation. Notable among these are uBiome (now rebranded as BiomeSense), which specializes in microbial genomics for health, disease, and lifestyle; Second Genome, a company that has developed a platform for microbiome science to influence disease treatment and prevention; and CosmosID, which offers microbial genomics solutions for infectious disease diagnostics and microbiome analysis Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.